Pinar Demirtepe: Not All “Blood Thinners” Are the Same
Pinar Demirtepe, Intensive Care Nurse at Ministry of Health of the Republic of Türkiye, shared a post on LInkedIn:
“One of the things I learned after starting to work in the Coronary Intensive Care Unit surprised me.
Many people, including healthcare professionals early in their careers, use the term ‘blood thinner’ for different medications. However, anticoagulants and antiplatelet drugs are not the same.
Anticoagulants mainly target the coagulation cascade and help prevent fibrin-rich clots, while antiplatelet drugs reduce platelet aggregation and are particularly important in arterial thrombosis, such as coronary artery disease.
Understanding the mechanism behind these medications is far more valuable than simply memorizing their names.
Every day in critical care reminds me how much there is still to learn—and that’s one of the things I enjoy most about this profession.”

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines